切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (05) : 549 -558. doi: 10.3877/cma.j.issn.1674-0807.2009.05.013

综述

黏附分子介导的信号转导与乳腺癌转移
李东梅1, 冯玉梅1   
  1. 1.300060 天津,天津医科大学附属肿瘤医院肿瘤研究所
  • 收稿日期:2009-04-02 出版日期:2009-10-01

Cell adhesion molecule-mediated signal transduction and breast cancer metastasis

Dong-mei LI, Yu-mei FENG   

  • Received:2009-04-02 Published:2009-10-01
引用本文:

李东梅, 冯玉梅. 黏附分子介导的信号转导与乳腺癌转移[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(05): 549-558.

Dong-mei LI, Yu-mei FENG. Cell adhesion molecule-mediated signal transduction and breast cancer metastasis[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(05): 549-558.

[1]
Shi maoka M,Takagi J,Springer T A.Conf or mational regulation of integrin str uct ure and f unction.Annu Rev Biophys Bio mol Str uct,2002,31:485-516.
[2]
Hannigan G,Tr oussar d A A,Dedhar S.Integrin-linked kinase:a cancer therapeutic tar get unique a mong its ILK.Nat Rev Cancer,2005,5:51-63.
[3]
Imanishi Y,Hu B,Jarzynka M J,et al.Angiopoietin-2 sti mulates breast cancer metastasis through the alpha(5)beta(1)integrin-mediated pathway.Cancer Res,2007,67:4254-4263.
[4]
ertotti A,Co moglio P M,Tr usolino L.Beta4 integrin activates a Shp2-Src signaling pat h way t hat sustains HGF-induced anchorage-independent gr owt h.J Cell Biol,2006,175:993-1003.
[5]
Matteucci E,Ridolfi E,Desiderio M A.Hepatocyte growth factor differently influences Met-E-cadherin phosphoryl-ation and downstreamsignaling pathway in t wo models of breast cells.Cell Mol Life Sci,2006,63:2016-2026.
[6]
Wang Y,Jin G,Miao H,et al.Integrins regulate VE-cadherin and catenins:dependence of t his regulation on Src,but not on Ras.Pr oc Natl Acad Sci USA,2006,103:1774-1779.
[7]
Keely P J,Rusyn E V,Cox A D,et al.R-Ras signals through specific integrin alpha cytoplas mic do mains to pro mote migration and invasion of breast epithelial cells.J Cell Biol,1999,145:1077-1088.
[8]
Ki m M S,Lee E J,Ki m H R,et al.p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in hu man breast epithelial cells.Cancer Res,2003,63:5454-5461.
[9]
Keely PJ,West wick J K,Whitehead I P,et al.Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K.Nature,1997,390:632-636.
[10]
augher PJ,Krishnamoorthy L,Price J E,et al.Rac1 and Rac3 isofor mactivation is involved in the invasive and metastatic phenotype of hu man breast cancer cells.Breast Cancer Res,2005,7:R965-974.
[11]
orozevich G E,Kozlova NI,Cheglakov I B,et al.Implication of alpha5 beta1 integrin in invasion of drug-resistant MCF-7/ADR breast carcinoma cells:a role for MMP-2 collagenase.Biochemistry(Mosc),2008,73:791-796.
[12]
as S,Banerji A,Frei E,et al.Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells(MCF-7)to fibronectin in serumfree medium.Life Sci,2008,82:467-476.
[13]
au m O,Hlushchuk R,Forster A,et al.Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit.Int J Oncol,2007,30:325-332.
[14]
uo mmino E,Boccellino M,De Filippis A,et al.3-O-methylf unicone pr oduced by penicilliu m pinophil u m aff ects cell motility of breast cancer cells,downregulating alphavbeta5 integrin and inhibiting metalloproteinase-9 secretion.Mol Carcinog,2007,46:930-940.
[15]
Morini M,Mottolese M,Ferrari N,et al.The al pha 3 beta 1 integrin is associated wit h mammary carcino ma cell metastasis,invasion,and gelatinase B (MMP-9)activity.Int J Cancer,2000,87:336-342.
[16]
Shao R,Bao S,Bai X,et al.Acquired expression of periostin by hu man breast cancers pr o motes t u mor angiogenesis t hr ough up-regulation of vascular endot helial gr owt h factor receptor 2 expression.Mol Cell Biol,2004,24:3992-4003.
[17]
hite D E,Muller WJ.Multifaceted roles of integrinsin breast cancer metastasis.J Mammary Gland Biol Neoplasia,2007,12:135-142.
[18]
hung J,Yoon S,Datta K,et al.Hypoxia-induced vascular endothelial growth factor transcription and protection fro mapoptosis are dependent on alpha6beta1 integrin in breast carcino ma cells.Cancer Res,2004,64:4711-4716.
[19]
lloul S,Elstrand M B,Nesland J M,et al.Snail,Slug,and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.Cancer,2005,103:1631-1643.
[20]
Huang W,Zhang Y,Varambally S,et al.Inhibition of CCN6(Wnt-1-induced signaling protein 3)down-regulates E-cadherin in the breast epitheliu mthrough induction of snail and ZEB1.Am J Pathol,2008,172:893-904.
[21]
ang S,Du J,Wang Z,et al.BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.BMC Cancer,2007,7:211.
[22]
atteucci E,Ridolfi E,Desiderio M A.Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in t wo models of breast cells.Cell Mol Life Sci,2006,63:2016-2026.
[23]
ennisi P A,Barr V,Nunez N P,et al.Reduced expression of insulin-like growth factor I receptorsin MCF-7 breast cancer cells leads to a more metastatic phenotype.Cancer Res.2002,62:6529-6537.
[24]
hibata T,Kokubu A,Sekine S,et al.Cytoplasmic p120ctn regulates the invasive phenotypes of Ecadherin-deficient breast cancer.Am J Pathol,2004,164:2269-2278.
[25]
aggioli C,Hooper S,Hidalgo-Carcedo C,et al.Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.Nat Cell Biol,2007,9:1392-1400.
[26]
avallaro U,Liebner S,Dejana E.Endothelial cadherins and tumor angiogenesis.Exp Cell Res,2006,312:659-667.
[27]
uyama K,Shapiro I,Gutt man M,et al.A signaling pathway leading to metastasis is controlled by Ncadherin and the FGF receptor.Cancer Cell,2002,2:301-314.
[28]
ulit J,Suyama K,Chung S,et al.N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.Cancer Res,2007,67:3106-3116.
[29]
otthoff S,Entschladen F,Niggemann B,et al.N-cadherin engagement provides a do minant stop signal for the migration of MDA-MB-468 breast carcinoma cells.Breast Cancer Res Treat,2007,105:287-295.
[30]
amura D,Hiraga T,Myoui A,et al.Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.Int J Oncol,2008,33:17-24.
[31]
arita T,Kawakami Ki mura N,Sato M,et al.Biological f unctions of cell adhesion molecules in breast cancer.Gan To Kagaku Ryoho,1996,23:56-60.
[32]
lpaugh M L,Tomlinson J S,Ye Y,et al.Relationship of sialyl-Lewis(x/a)underexpression and Ecadherin overexpression in the ly mphovascular embolus of inflam-matory breast carcinoma.Am J Pathol,2002,161:619-628.
[33]
lpaugh M L,Tomlinson J S,Kasraeian S,et al.Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tu mor emboli in inflammatory breast carcinoma.Oncogene,2002,21:3631-3643.
[34]
Gout S,Morin C,Houle F,et a1.Death receptor-3:a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by trigering p38 and ERK MAPK activation.Cancer Res,2006,66:9117-9124.
[35]
eyes M E,George M D,Roberts J D,et al.P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin.Exp Cell Res,2006,312:4056-4069.
[36]
hompson P W,Randi A M,Ridley A J.Intercellular adhesion molecule(ICAM)-1,but not ICAM-2,activates Rho A and sti mulates c-fos and rho A transcription in endothelial cells.J Immunol,2002,169:1007-1013.
[37]
Rahn J J,Shen Q,Mah B K,et al.MUC1 initiates a calciu m signal after ligation by intercellular adhesion molecule-1.J Biol Chem,2004,279:29 386-29 390.
[38]
ahn JJ,Chow J W,Horne GJ,et al.MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.Clin Exp Metastasis,2005,22:475-483.
[39]
Shen Q,Rahn J J,Zhang J,et al.MUC1 initiates Src-Crk L-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1. Mol Cancer Res,2008,6:555-567.
[40]
akahashi M,Furihata M,Aki mitsu N,et al.A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1.Clin Exp Metastasis,2008,25:517-529.
[41]
Markowska A,Urasińska E,Do maga W.In vitro assess ment of adhesion molecules expression by human endothelial cells cocultured with c-erbB2-positive and c-erbB2-negative breast carcinoma cell lines.Pol J Pathol,2008,59:49-54.
[42]
u Q,Stamenkovic I.Localization of matrix metalloproteinase 9 to the cell surface provides a mechanis mfor CD44-mediated tu mor invasion.Genes Dev,1999,13:35-48.
[43]
eng S T,Su C H,Kuo C C,et al.CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tu mor cells leads to enhanced metastasis.Int J Oncol,2007,31:1119-1126.
[44]
u Q,Stamenkovic I.Transfor ming growth factor-beta facilitates breast carcinoma metastasis by promoting tu mor cell survival.Clin Exp Metastasis,2004,21:235-242.
[45]
u Q,Stamenkovic I.Cell surface-localized matrix metallopro-teinase-9 proteolytically activates TGFbeta and promotes tu mor invasion and angiogenesis.Genes Dev,2000,14:163-176.
[46]
Mine S,Fujisaki T,Kawahara C,et al.Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44.Exp Cell Res,2003,288:189-197.
[47]
Zen K,Liu D Q,Guo Y L,et al.CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.PLoS One,2008,3:e1826.
[48]
Wang H S,Hung Y,Su C H,et al.CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1(alpha L beta2)and VLA-4(alpha4beta1).Exp Cell Res,2005,304:116-126.
[49]
lemke M,Weschenfelder T,Konstandin M H,et al.High affinity interaction of integrin alpha4beta1(VLA-4)and vascular cell adhesion molecule 1(VCAM-1)enhances migration of human melanoma cells across activated endothelial cell layers.J Cell Physiol,2007,212:368-374.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[6] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[7] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[8] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[9] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[10] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[11] 孙璐, 蒋亚玲, 陈凌君. 布托啡诺对脑缺血再灌注损伤大鼠神经炎症和JAK2/STAT3信号通路的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 344-350.
[12] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[13] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[14] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[15] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
阅读次数
全文


摘要